Sponsors: []Modifications:      26-55-108.(1)  As used in this section:(a)  "Controlled substance prescriber" means the same as that term is defined in Section58-37-6.5.(b)  "Coprescribe" means to issue a prescription for an opiate antagonist with aprescription for an opiate.(2)  The department shall, in consultation with the Physicians Licensing Board createdin Section 58-67-201, the Osteopathic Physician and Surgeon's Licensing Board created inSection 58-68-201, and the Department of Occupational and Professional Licensing created inSection 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, UtahAdministrative Rulemaking Act, scientifically based guidelines for controlled substanceprescribers to coprescribe an opiate antagonist to a patient.(3)  The department shall report to the Health and Human Services Interim Committeebefore October 30, 2017, regarding the guidelines established under Subsection (2).(4)  The report described in Subsection (3) shall include:(a)  established rules regarding the coprescription of an opiate antagonist to a patient;and(b)  an analysis of:(i)  the application of the rules; and(ii)  the impact of the rules.Full text:



1     ADDICTION RECOVERY AMENDMENTS2     2017 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Karen  Mayne5     House Sponsor:  Mike K. McKell6      7     LONG TITLE8     General Description:9           This bill amends the Opiate Overdose Response Act. 10     Highlighted Provisions:11          This bill:12                 defines terms; and13                requires the Department of Health to:14                     establish guidelines for the issuance of a prescription for an opiate antagonist15     along with a prescription for an opiate; and16                     report on the guidelines to the Health and Human Services Interim Committee. 17     Money Appropriated in this Bill:18          None19     Other Special Clauses:20          None21     Utah Code Sections Affected:22     ENACTS:23          26-55-108, Utah Code Annotated 195324      25     Be it enacted by the Legislature of the state of Utah:26          Section 1.  Section 26-55-108 is enacted to read:27          26-55-108. Coprescription guidelines -- Reporting.28          (1)  As used in this section:29          (a)  "Controlled substance prescriber" means the same as that term is defined in Section30     58-37-6.5.31          (b)  "Coprescribe" means to issue a prescription for an opiate antagonist with a32     prescription for an opiate.33          (2)  The department shall, in consultation with the Physicians Licensing Board created34     in Section 58-67-201, the Osteopathic Physician and Surgeon's Licensing Board created in35     Section 58-68-201, and the Department of Occupational and Professional Licensing created in36     Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah37     Administrative Rulemaking Act, scientifically based guidelines for controlled substance38     prescribers to coprescribe an opiate antagonist to a patient.39          (3)  The department shall report to the Health and Human Services Interim Committee40     before October 30, 2017, regarding the guidelines established under Subsection (2).41          (4)  The report described in Subsection (3) shall include:42          (a)  established rules regarding the coprescription of an opiate antagonist to a patient;43     and44          (b)  an analysis of:45          (i)  the application of the rules; and46          (ii)  the impact of the rules.

